Securities Times Network News: Sanofi has received a sell rating from Deutsche Bank with a target price of 85 euros. Sanofi is a leading pharmaceutical company in Europe, mainly engaged in pharmaceuticals, human vaccines, and consumer health products, with pharmaceuticals accounting for the highest proportion at 70.6%. The company has 54 production bases worldwide, distributed geographically, with the United States being its largest market, accounting for 43%. As of the end of 2023, Sanofi has 86088 employees. Recently, Sanofi has partnered with Indapta Therapeutics to conduct clinical research on multiple myeloma. In addition, Sanofi has announced plans to invest 1 billion euros in Beijing to build a new insulin production base.